These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 25447132)

  • 41. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli.
    McCarthy ET; Sharma M; Sharma R; Falk RJ; Jennette JC
    J Lab Clin Med; 2004 Apr; 143(4):225-9. PubMed ID: 15085081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology of focal segmental glomerulosclerosis.
    Reidy K; Kaskel FJ
    Pediatr Nephrol; 2007 Mar; 22(3):350-4. PubMed ID: 17216262
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Towards a biological characterization of focal segmental glomerulosclerosis.
    Devarajan P; Spitzer A
    Am J Kidney Dis; 2002 Mar; 39(3):625-36. PubMed ID: 11877584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function.
    Sener A; Bella AJ; Nguan C; Luke PP; House AA
    Clin Transplant; 2009; 23(1):96-100. PubMed ID: 19200221
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Focal Segmental Glomerulosclerosis.
    Suresh V; Stillman IE; Campbell KN; Meliambro K
    Adv Kidney Dis Health; 2024 Jul; 31(4):275-289. PubMed ID: 39084753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathologic classification of focal segmental glomerulosclerosis.
    D'Agati V
    Semin Nephrol; 2003 Mar; 23(2):117-34. PubMed ID: 12704572
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [The role of podocyte damage in the pathogenesis of glomerulosclerosis and possible repair mechanisms].
    Ronconi E; Mazzinghi B; Sagrinati C; Angelotti ML; Ballerini L; Parente E; Romagnani P; Lazzeri E; Lasagni L
    G Ital Nefrol; 2009; 26(6):660-9. PubMed ID: 19918748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis.
    Batal I; Khairallah P; Weins A; Andeen NK; Stokes MB
    Front Immunol; 2023; 14():1124249. PubMed ID: 36911713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal artery stenosis and unilateral focal and segmental glomerulosclerosis.
    Alkhunaizi AM; Chapman A
    Am J Kidney Dis; 1997 Jun; 29(6):936-41. PubMed ID: 9186081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Angiotensin antagonists and steroids in the treatment of focal segmental glomerulosclerosis.
    Korbet SM
    Semin Nephrol; 2003 Mar; 23(2):219-28. PubMed ID: 12704582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features.
    Stokes MB; Valeri AM; Markowitz GS; D'Agati VD
    Kidney Int; 2006 Nov; 70(10):1783-92. PubMed ID: 17021605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation.
    Jungraithmayr TC; Bulla M; Dippell J; Greiner C; Griebel M; Leichter HE; Plank C; Tönshoff B; Weber LT; Zimmerhackl LB;
    Pediatr Transplant; 2005 Apr; 9(2):226-31. PubMed ID: 15787798
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathology of recurrent diseases in kidney allografts: membranous nephropathy and focal segmental glomerulosclerosis.
    Kowalewska J
    Curr Opin Organ Transplant; 2013 Jun; 18(3):313-8. PubMed ID: 23619512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice.
    Rood IM; Deegens JK; Wetzels JF
    Nephrol Dial Transplant; 2012 Mar; 27(3):882-90. PubMed ID: 22334613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants.
    Thomas DB; Franceschini N; Hogan SL; Ten Holder S; Jennette CE; Falk RJ; Jennette JC
    Kidney Int; 2006 Mar; 69(5):920-6. PubMed ID: 16518352
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
    J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pre-transplant angiotensin receptor II type 1 antibodies and risk of post-transplant focal segmental glomerulosclerosis recurrence.
    Mujtaba MA; Sharfuddin AA; Book BL; Goggins WC; Khalil AA; Mishler DP; Fridell JA; Yaqub MS; Taber TE
    Clin Transplant; 2015 Jul; 29(7):606-11. PubMed ID: 25973696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Characteristics of repeated renal biopsy-proven primary focal segmental glomerulosclerosis in children].
    He RJ; Xiao HJ; Liu JC; Wang SX; Yang JY
    Zhonghua Er Ke Za Zhi; 2012 Apr; 50(4):298-300. PubMed ID: 22801235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View.
    Kronbichler A; Saleem MA; Meijers B; Shin JI
    J Immunol Res; 2016; 2016():2068691. PubMed ID: 27504461
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.
    Wen Y; Shah S; Campbell KN
    Front Med (Lausanne); 2018; 5():98. PubMed ID: 29713631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.